ECT2 promotes malignant phenotypes through the activation of the AKT/mTOR pathway and cisplatin resistance in cervical cancer
Xiaoli Liu, Junhua Zhang, Shuang Ju, Lu Liu, Yu Sun, Lingyu Guo, Qianwei Zhen, Sai Han, Wei Lü, Youzhong Zhang
Topics & Concepts
Gene knockdownPI3K/AKT/mTOR pathwayCisplatinProtein kinase BCancer researchGene silencingApoptosisMetastasisCancerBiologyMedicineInternal medicineGeneGeneticsChemotherapyEpigenetics and DNA MethylationCancer-related gene regulationRNA modifications and cancer